Advertisement

European Journal of Clinical Pharmacology

, Volume 21, Issue 1, pp 1–8 | Cite as

Combination therapy in hypertension

A population-based study in Eastern Finland
  • H. Enlund
  • H. Turakka
  • J. Tuomilehto
Original

Summary

In a cross-sectional study, antihypertensive drug treatment was studied in a representative population sample of people aged 30–64 years, using a combination of postal survey, personal interview, clinical assessment and drug prescriptions. 11% of the men and 16% of the women were currently taking antihypertensives; 54% of patients used one, 38% used two, and 8% used three or more preparations. Men used slightly more drugs than women. Diuretics were used by 62% and betablockers by 49% of the sample population. Fixed combinations of thiazides and potassium-sparing agents formed 70% of all diuretic preparations used. Only 12% of the patients used fixed antihypertensive combinations, of which over half were diuretic-reserpine-vasodilator combinations; women and older patients used them most often. The most common freely combined preparations were diuretics and betablockers, which formed almost half of all two-drug combinations, and were also present in 70% of all triple combinations. Adequate control of blood pressure (DBP <100 mmHg) was achieved by slightly under 50% of the patients, the BP of women being more adequately controlled than that of men. Differences in BP control were found between the different drugs and combinations. Antihypertensive combination therapy is important in successful treatment, but we still cannot be sure whether fixed combination preparations or, as in this study, free combinations of marketed preparations are better alternatives for treatment.

Key words

hypertension combination therapy population survey drug treatment prescription patterns population incidence 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Angervall G, Bystedt U (1974) The effect of alprenolol in combination with saluretics in hypertension. Acta Med Scand (Suppl) 554: 39–45Google Scholar
  2. Armitage P (1971) Statistical Methods in Medical Research. Blackwell, OxfordGoogle Scholar
  3. Ayd FJ Jr (1974) Single daily dose of antidepressants. J Am Med Assoc 230: 263–264Google Scholar
  4. Berglund G, Wilhelmsen L, Sannerstedt R, Hansson L, Andersson O, Sivertsson R, Wedel H, Wikstrand J (1978) Coronary heart disease after treatment of hypertension. Lancet 1: 1–5Google Scholar
  5. Colwill JM, Dutton AM, Morrissey J, Yu PN (1964) Alpha-metyldopa and hydrochlorothiazide. A controlled study of their comparative effectiveness as antihypertensive agents. N Engl J Med 271: 696–703Google Scholar
  6. Council of Europe (1975) Abuse of medicines. Report by a Working Party (1972–1973), StrasbourgGoogle Scholar
  7. Dengler HJ, Lasagna L (1975) Report of a workshop on fixed-ratio drug combinations. Eur J Clin Pharmacol 8: 149–150Google Scholar
  8. Dollery CT (1977) Pharmacological basis for combination therapy of hypertension. Annu Rev Pharmacol Toxicol 17: 311–323.Google Scholar
  9. Dollery CT, Bulpitt CJ (1977) Management of hypertension. In: Genest J, Koiw E, Kuchel O (eds). Hypertension. Pathophysiology and treatment. McGraw-Hill, New York, pp 1038–1068Google Scholar
  10. Engelland AL, Alderman MH, Powell HB (1979) Blood pressure control in private practice: A case report. Am J Publ Health 69: 25–29Google Scholar
  11. Enlund H, Tuomilehto J, Turakka H (1981) Patient report validated against prescription records for measuring the use of and compliance with antihypertensive drugs. Acta Med Scand 209: 271–276Google Scholar
  12. Hamblin D, Wells FO, Ellis S (1979) A study of the compliance to prescribed treatment of patients on antihypertensive therapy. J Clin Pharmacy 4: 41–49Google Scholar
  13. Hansson L, Hood B (1977) Antihypertensiva medel 2:1. Social-styrelsens Kommitte för LäkemedelsinformationGoogle Scholar
  14. Heinonen OP (1972) Remedia Fennica, HelsinkiGoogle Scholar
  15. Helfand WH (1979) Worldwide patterns of combination drug usage. Eur J Clin Pharmacol 16: 221–228Google Scholar
  16. Idänpään-Heikkilä J (1978) Kardiovaskulaaristen lääkkeiden kulutus Pohjoismaissa ja eräissä muissa Euroopan maissa. In: Lääketiede 79, Helsinki, pp 578–580Google Scholar
  17. Jellet LB (1978) Potassium therapy: When is it indicated? Drugs 16: 88–94Google Scholar
  18. Nordic Statistics on Medicines. Statistical reports of the Nordic Countries 35. Helsingfors 1979Google Scholar
  19. O'Brien ET, MacKinnon J (1972) Propranolol and Polythiazide in treatment of hypertension. Br Heart J 34: 1042–1044Google Scholar
  20. Parkin DM, Henney CR, Qvirck J, Crooks J (1976) Deviation from prescribed drug treatment after discharge from hospital. Br Med J 2: 686–688Google Scholar
  21. Pharmaca Fennica (1977) Lääkevalmisteet, RaumaGoogle Scholar
  22. Pharmaca Fennica (1980) Lääkevalmisteet, RaumaGoogle Scholar
  23. Puska P, Tuomilehto J, Salonen J, Neittaanmäki L, Mäki J, Virtamo J, Nissinen A, Koskela K, Takalo T (1979) Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular disease (North Karelia project). Br Med J 2: 1173–1178Google Scholar
  24. Puska P, Neittaanmäki L, Tuomilehto J (1981) Participation experiences and opinions of local health personnel and decision makers concerning a community program for control of cardiovascular diseases. Prev Med (in press)Google Scholar
  25. Rose G, Blackburn H (1968) Cardiovascular survey methods. WHO Monogr Ser 56, GenevaGoogle Scholar
  26. Siltanen P, Savolainen E, Hartikainen M, Luomanmäki K, Siltanen P (1976) Verenpainetaudin hoitotilanne keväällä 1975. Suom Lääk L 31: 2322–2330Google Scholar
  27. Social Insurance Institution (1980) Publication T9: 21, HelsinkiGoogle Scholar
  28. Tuomilehto J, Björkqvist S, Mäki J, Nissinen A (1977) Verenpaineen lääkehoito Pohjois-Karjalassa vuonna 1975. Suom Lääk L 32: 529–532Google Scholar
  29. Tuomilehto J, Nissinen A, Salonen JT, Kottke TE, Puska P (1980) Community programme for control of hypertension in North Karelia, Finland. Lancet 2: 900–904Google Scholar
  30. Turakka H, Enlund H, Tuomilehto J (1979) Drug use and patient compliance in hypertension therapy. In: Schaaf D, Kleijn E van der (eds) Progress in clinical pharmacy. Elsevier, Amsterdam, pp 53–60Google Scholar
  31. Wagner EH, Slome C, Carroll CL, Warner JT, Pittman AW, Pickard CG, Williams BO, Cornon-Huntley JC (1980) Hypertension control in a rural biracial community: Success and failures of primary care. Am J Publ Health 70: 48–55Google Scholar
  32. Wilber JA, Barrow JG (1972) Hypertension — a community problem. Am J Med 52: 653–663Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • H. Enlund
    • 1
  • H. Turakka
    • 1
  • J. Tuomilehto
    • 2
  1. 1.Department of Community Health, Division of Social PharmacyUniversity of KuopioKuopioFinland
  2. 2.North Karelia ProjectUniversity of KuopioKuopioFinland

Personalised recommendations